3 completed, 3 unknown. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 3, Unknown 3 |
Follow Red-Cell Aplasia, Pure: new trials by email Literature Review of Red-Cell Aplasia, Pure trials Research Report on Red-Cell Aplasia, Pure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sirolimus Treatment for Newly Diagnosed Primary Acquired PRCA Sirolimus, Cyclosporine A - Pure Red Cell Aplasia, Acquired | Phase 4 | Completed | Bing Han | 56 | 2020-07-01 | 2023-02-28 |
| Tacrolimus Treatment for Refractory Autoimmune Cytopenia Tacrolimus - Autoimmune Hemolytic Anemia, Pure Red Cell Aplasia | Phase 4 | Unknown | Peking Union Medical College Hospital | 80 | 2019-05-04 | 2019-12-03 |
| Tacrolimus Treatment for Refractory PRCA tacrolimus - Pure Red Cell Aplasia | Phase 4 | Unknown | Peking Union Medical College Hospital | 30 | 2018-06-10 | 2018-05-30 |
| Sirolimus Treatment for Refractory PRCA Sirolimus - Pure Red Cell Aplasia | Phase 4 | Completed | Bing Han | 64 | 2018-02-01 | 2021-07-06 |
| Pure Red Cell Aplasia in Patients With Chronic Kidney Disease and in Use of Epoetin Alfa Pure Red Cell Aplasia diagnostic confirmation - Red-Cell Aplasia, Pure, Renal Insufficiency, Chronic | Phase 4 | Unknown | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 531 | 2015-11-01 | 2016-01-06 |
| Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload deferasirox - Hemoglobinopathies, Myelodysplastic Syndromes | Phase 4 | Completed | Novartis | 118 | 2007-11-01 | 2017-02-23 |
Anemia, Diamond-Blackfan (1) · Anemia, Hemolytic, Autoimmune (1) · Evans Syndrome (1) · Fibromyalgia (1) · Hemoglobinopathies (1) · Myelodysplastic Syndromes (1) · Renal Insufficiency, Chronic (1)
Anemia (6) · Hematologic Diseases (6) · Hemic and Lymphatic Diseases (6) · Anemia, Aplastic (1) · Anemia, Hemolytic (1) · Anemia, Hypoplastic, Congenital (1) · Autoimmune Diseases (1) · Bone Marrow Diseases (1) · Bone Marrow Failure Disorders (1) · Chronic Disease (1) · Congenital Bone Marrow Failure Syndromes (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1)
Sirolimus (2) · Tacrolimus (2) · Cyclosporine (1) · Deferasirox (1)
Bing Han (2) · Peking Union Medical College Hospital (2) · Novartis (1) · The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) (1)
China (4) · Australia (1)
Bing B Han, PhD. (1) · Bing Han, PhD (1) · Bing Hang, PhD (1) · Vivian Rotman, M.D. (1)
PMID 19208097, PMID 24363761, PMID 26504182, PMID 27881371, PMID 21168455, PMID 22471345, PMID 27537786, PMID 29982851, PMID 32030447, PMID 37160872